[ad_1]
A global anti-epidemiological alliance plans to invest up to $ 8.4 million in the development of a technology to produce adaptive industrial vaccines tailored to each disease, making it possible to combat many diseases. bacteria and viruses, such as influenza, Ebola and rabies.
The agreement concluded between the Alliance of Innovations for Pandemic Preparedness and a team of scientists from Imperial College London aims to develop a "vaccine platform" using technology that allows 39, ribosome DNA to represent the genome of a strain of virus and clone it and multiply, its capabilities, known as the technique known as (SA / RNA).
The "vaccine platform" is used with essential components and can then be modified to immunize against various diseases by adding a new gene sequence of the target disease.
"This could be a huge step forward," said Robin Shattuck, who heads the Imperial team responsible for developing the RapidVac system. Can change the way we look at how vaccines are made. "
He added that many years of research and testing were still needed, but he hoped that someday technology would produce vaccines that would be taken only once to prevent a single pandemic or to produce a vaccine. mixture of vaccines protected from several different infectious diseases at the same time.
The idea behind this technique is to simulate how the cells of the body produce a disease-resistant serum, which involves the introduction of a stimulating foreign body a immune response instead of injecting it directly to the body with the same serum.
[ad_2]
Source link
